CX Institutional’s Fidelity MSCI Financials Index ETF FNCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Buy
287
+1
+0.3% +$74 ﹤0.01% 1155
2026
Q1
$20K Sell
286
-743
-72% -$55.2K ﹤0.01% 1127
2025
Q4
$80K Buy
1,029
+728
+242% +$55K ﹤0.01% 890
2025
Q3
$23K Sell
301
-1,177
-80% -$88.7K ﹤0.01% 1071
2025
Q2
$109K Buy
1,478
+1,093
+284% +$75.8K ﹤0.01% 750
2025
Q1
$27K Buy
+385
New +$27.3K ﹤0.01% 917
2024
Q3
Sell
-23,838
Closed -$1.38M 565
2024
Q2
$1.38M Buy
23,838
+436
+2% +$25.2K 0.06% 229
2024
Q1
$1.39M Buy
23,402
+237
+1% +$13.2K 0.07% 230
2023
Q4
$1.24M Buy
23,165
+13,845
+149% +$675K 0.07% 232
2023
Q3
$434K Sell
9,320
-3,502
-27% -$169K 0.02% 348
2023
Q2
$604K Sell
12,822
-90,730
-88% -$4.12M 0.03% 332
2023
Q1
$4.67M Buy
+103,552
New +$5.07M 0.25% 112

Other funds holding FNCL

CX Institutional's FNCL Position: Q2 2026 in Review

CX Institutional increased its Fidelity MSCI Financials Index ETF (FNCL) stake by 0.35% in Q2 2026, buying an estimated $74 and bringing the position to 287 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

CX Institutional first reported a position in FNCL in Q1 2023 and has held it in 12 quarters since. The position peaked at $4.67M in Q1 2023. 255 funds tracked by Wall St. Rank hold FNCL as of Q2 2026.

  • CX Institutional held 287 shares of Fidelity MSCI Financials Index ETF worth $22K as of Q2 2026.
  • CX Institutional bought 1 Fidelity MSCI Financials Index ETF share in Q2 2026, an estimated $74.
  • Fidelity MSCI Financials Index ETF made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1155 holding.
  • CX Institutional first reported a position in Fidelity MSCI Financials Index ETF in Q1 2023 and has held it in 12 quarters since.
  • CX Institutional's Fidelity MSCI Financials Index ETF position peaked at $4.67M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held Fidelity MSCI Financials Index ETF as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.